Please see the attached articles of association of Genmab A/S dated November 5, 2008.
Recommended Reading
-
November 5, 2026 Copenhagen, Denmark; Interim Report for the Nine Months Ended September 30, 2026 Highlights Epcoritamab approved in Europe (as TEPKINLY®) and Japan (as EPKINLY®) in combination with...
Read More -
Media Release COPENHAGEN, Denmark; November 4, 2026 Twenty-two abstracts underscore the versatility of epcoritamab as monotherapy and in combination across multiple disease subtypes and in...
Read More